N/A N=300 Impact of Adding a Limitation Section in Abstract of Systematic Review
Systematic Review
Primary: Confidence in the Results of the Systematic Review — 4.6; 4.4 score on a scale — p=0.5
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=171 Presenting Summary Information From Cochrane Systematic Reviews
Understanding Cochrane Systematic Reviews
Primary: Understanding — 6.0; 6.0; 5.0 units on a scale
N/A N=108 Presenting Summary Information From Cochrane Systematic Reviews to Physicians
Health Knowledge, Attitudes, Practice
Primary: Understanding of the Content of Summary Format — 8.0; 8.0; 8.0 units on a scale
N/A N=212 Presenting Summary Information From Cochrane Systematic Reviews: Protocol for Research of Infographics Presentation vs. Plain Language Summary
Health Knowledge, Attitudes, Practice
Primary: Understanding of the Summary Content — 7.0; 7.0 units on a scale
N/A N=129 Contacting Authors to Retrieve Individual Patient Data
Response Rates
Primary: Proportion of Authors Who Provided Complete IPD — 0; 0 Participants
N/A N=216 Practice Guidelines Grading Systems
Decision Making
Primary: Change in Behavior in Physicians Attitude Towards a Decision to Give a Medication — 2.18; 0.31; 0.04; 0.08 Mean change in centimeters — p=0.007
N/A N=41 The Evaluation of a CONSORT Based Online Writing Tool
Focus of Study = Medical Writing
Primary: The Primary Outcome Will be the Average Score for Completeness of Reporting on a Scale of 0-10. — 7.1; 5.0 units on a scale — p=<0.001
N/A N=128 A Retrospective Study of the Navio Robotic-assisted Surgical System
Surgical Robotics · Knee Replacement
Primary: Evaluate the Navio™ System for Revisions at 2+ Years Post-surgical Implantation Survivorship — 0; 0; 1; 0 participants
N/A N=300 Impact of "Spin" on the Interpretation of Results of Randomized Trials in the Field of Cancer
the Study Focus on no Specific Condition
Primary: Interpretation of the Beneficial Effect of the Experimental Treatment — 3.6; 2.9 score on a scale — p=0.03
N/A N=155 Imagio Feasibility Multi-Reader, Multi-Case Study
Breast Cancer
Primary: The Gain in Imagio IUS Alone Specificity vs Imagio (IUS+OA) Specificity at Fixed 95-99% Sensitivity (fSp), Cohort 1 — 80.9; 75.4; 78.7; 71.4 Percent of correct benign…
N/A N=372 Retrospective Chart Review of the 5 & 2 & 2 and 4 & 2 & 1 Plans
Obesity
Primary: Body Weight — -28.35; -23.95 Pounds — p=<0.0001
N/A N=32 A Retrospective Review Evaluating the Matrix Pro Applicator for Treatment of Wrinkles
Wrinkle
Primary: Improvement in Facial Wrinkles — 24 Participants
N/A N=172 Systematic Multi-domain Alzheimer's Risk Reduction Trial
Dementia · Alzheimer Disease
Primary: Cognitive Change — 0.34; 0.19 z-score — p=0.008
N/A N=278 Retrospective Review of Mechanically Ventilated Patients Using a Continuous Data Collection System.
Mechanical Ventilation · Acute Respiratory Distress Syndrome · Hypoxic Respiratory Failure
Primary: Successful Extubation — 58; 222 Participants
N/A N=517 Swedish Adjustable Gastric Banding Observational Cohort Study
Obesity, Morbid
Primary: Mean BMI Change — -9.03 kg/m^2
N/A N=6,274 Comparing Types of Implementation of a Shared Decision Making Intervention
Asthma
Primary: Patient Perception of Shared Decision Making — 34; 40; 86; 79 Participants
N/A N=2,165 Patterns of Care and Outcomes in METAstatic Soft Tissue SARComa
Sarcoma · Metastases · Chemotherapy
Primary: Correlation Between Time to Next Treatment (TNT) and Overall Survival (OS) Under First-line Treatment — 0.76 correlation coefficient
N/A N=130 Effectiveness of Implementing Shared Decision-Making on Quality of Care Among Patients With Lumbar Degenerative Diseases.
Lumbar Degenerative Disease · Shared Decision Making · Patient Decision Aids
Primary: The Change of Patients' Control Preference — 1; 1; 16; 14 Participants
N/A N=400 Effectiveness of an Evidence-based Stepped Care System for Alcohol and Other Drug Use Problems Among Congolese Refugees in Zambia
Alcohol and Substance-Related Mental Disorders
Primary: Change in Alcohol Use Disorders Identification Test (AUDIT) Score — -12.6; -8.1; -13.8; -10.3 score on a scale
N/A N=1,436 Implementing Systematic Distress Screening in Breast Cancer
Breast Cancer
Primary: Number of Participants Offered and Screened for Distress — 596; 3 Participants
N/A N=60 EHR Embedded Comparative Effectiveness Studies--WWC
Obesity
Primary: Compliance Rate — 87; 76 percentage of participants
N/A N=162 Randomized Controlled Trial (RCT) of a Motivational Decision Support System
Schizophrenia
Primary: Number of Subjects That Initiated Cessation Treatment — 27; 36 participants
N/A N=3,632 Epidemiological Study of the COVID-2019 in Participating Organizations.
Covid19
Primary: The Incidence of COVID-2019 Cases. — 259.95 COVID-2019 cases per 1000 person
N/A N=1,499 The Pharmacist Follows You and Your Medication From Hospital to Your Daily Life and Investigate What This Means to You
Cross-Sectional Study
Primary: Readmissions — 111; 98; 68 Participants
N/A N=62 Randomised, Controlled Trial of an Individual Deprescribing Intervention for Nursing Homes Residents
Polypharmacy · Inappropriate Prescribing
Primary: Number of Inappropriate Medication at Follow-up — 4.35; 4.85 drugs — p=0.723
N/A N=69 Sonendo GentleWave™ System for Treatment in Molar Teeth Requiring Root Canal Therapy
Root Canal Therapy
Primary: Number of Participants With a PAI Score of < 3, = 3, or = 4 or 5 — 51; 3; 0 Participants
N/A N=419 Evaluation of The MetaNeb® System to Reduce Postoperative Pulmonary Complications
Atelectasis · Pulmonary Complications
Primary: Significant Postoperative Pulmonary Complication Incidence. — 48; 33; 162; 176 Participants
N/A N=95 Comparison of ARPE Prosthesis With the Literature
Arthritis
Primary: Grip Strength — 17.8; 23.4; 24.7; 25 kg
N/A N=289 Comparative Effectiveness Trail to Reduce Child Maltreatment, Improve Client Outcomes and Examine Client Burden
Child Maltreatment
Primary: Parenting Young Children Scale-Supporting Positive Behavior Sub-scale — 6.14; 6.29; 6.43; 6.29 units on a scale — p=0.12
N/A N=93 Macrolane Retrospective Study
Women Who Have Had Breast Enhancement With Macrolane VRF
Primary: Number of Adverse Events — 46 number of AE